1027039

Grzegorz Kania, MD — FEI 3013644403

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 29, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Skierniewice (Poland)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance